MSH2 and cancer: A yeast test showed that overexpression of Msh6 can promote cancer-related gene rearrangements, while joint overexpression of Msh2 and Msh6 led to genomic instability, increased mutagenicity, and heightened sensitivity to DNA replication inhibitors and genotoxic agents, promoting tumor progression-like effects [16].